Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-β in combination with an analogue of 1α ,25-dihydroxyvitamin-D3.

MLA

Gysemans, C., et al. “Treatment of Autoimmune Diabetes Recurrence in Non-Obese Diabetic Mice by Mouse Interferon-β in Combination with an Analogue of 1α ,25-Dihydroxyvitamin-D3.” Clinical & Experimental Immunology, vol. 128, no. 2, May 2002, pp. 213–20. EBSCOhost, https://doi.org/10.1046/j.1365-2249.2002.01825.x.

APA

Gysemans, C., Etten, E. V., Overbergh, L., Verstuyf, A., Waer, M., Bouillon, R., & Mathieu, C. (2002). Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-β in combination with an analogue of 1α ,25-dihydroxyvitamin-D3. Clinical & Experimental Immunology, 128(2), 213–220. https://doi.org/10.1046/j.1365-2249.2002.01825.x

Chicago

Gysemans, C, E. Van Etten, L Overbergh, A Verstuyf, M Waer, R Bouillon, and C Mathieu. 2002. “Treatment of Autoimmune Diabetes Recurrence in Non-Obese Diabetic Mice by Mouse Interferon-β in Combination with an Analogue of 1α ,25-Dihydroxyvitamin-D3.” Clinical & Experimental Immunology 128 (2): 213–20. doi:10.1046/j.1365-2249.2002.01825.x.